Kazumasa Okubo Selected Research

3-cyanoalanine

7/2010

Upregulation of Ca(v)3.2 T-type calcium channels targeted by endogenous hydrogen sulfide contributes to maintenance of neuropathic pain.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kazumasa Okubo Research Topics

Disease

4	Hyperalgesia 01/2013 - 07/2010
3	Neuralgia (Stump Neuralgia) 01/2013 - 07/2010
1	Rotator Cuff Injuries 01/2021
1	Hypertrophy 12/2018
1	Sarcopenia 12/2018
1	Muscular Atrophy (Muscle Atrophy) 01/2018
1	Nociceptive Pain 07/2012
1	Neoplasms (Cancer) 06/2012

Drug/Important Bio-Agent (IBA)

3	T-Type Calcium Channels (T-Type Calcium Channel)IBA 07/2012 - 07/2010
2	MibefradilIBA 07/2012 - 07/2010
2	Hydrogen Sulfide (Sulfide, Hydrogen)IBA 07/2012 - 07/2010
2	Ascorbic Acid (Vitamin C)FDA LinkGeneric 07/2012 - 06/2012
2	sodium bisulfide (NaHS)IBA 07/2012 - 06/2012
1	Retinoic Acid Receptors (Retinoic Acid Receptor)IBA 01/2021
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 12/2018
1	Opioid Receptors (Opioid Receptor)IBA 01/2013
1	Buprenorphine (Subutex)FDA LinkGeneric 01/2013
1	GasotransmittersIBA 07/2012
1	zinc chloride FDA Link 07/2012
1	NNC 55-0396IBA 07/2012
1	TRPA1 Cation ChannelIBA 07/2012
1	Protein Isoforms (Isoforms)IBA 07/2012
1	disodium isostearyl 2-O-L-ascorbyl phosphateIBA 06/2012
1	Ointments (Pastes)IBA 06/2012
1	Paclitaxel (Taxol)FDA LinkGeneric 06/2012
1	Pharmaceutical PreparationsIBA 06/2012
1	3-cyanoalanineIBA 07/2010
1	Small Interfering RNA (siRNA)IBA 07/2010
1	propargylglycineIBA 07/2010

Therapy/Procedure

1	Denervation 01/2018